Answers are grounded in this paper and cite their sources.
Sulfasalazine is a drug commonly used in rheumatology and gastrology, unfortunately, up to 50% of patients report side effects during therapy. Most of them have a mild course and their significant factor is the genetically determined metabolism of the drug, which leads to the accumulation of the metabolite — sulfapyridine, responsible for toxic symptoms. Serious side effects are less frequent and may have varied pathomechanisms. Usually, they are difficult to recognize because in the early period they can imitate the course of many inflammatory and systemic diseases, therefore their appearance is not immediately associated with the patient’s intake of sulfasalazine, which may delay proper management and be fatal for the patient. This work aimed to present the serious complications that were observed in patients treated with sulfasalazine, i.e. drug rash with eosinophilia and systemic symptoms (DRESS syndrome), febrile neutropenia and severe nephrotic syndrome. Diagnostic and therapeutic difficulties in individual disease entities were discussed.
No takes yet. Share an insight, caveat, or question.
Osieleniec et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: